Sales of nutritional products including dietary supplements advertised as beneficial for consumers using glucagon-like peptide-1 receptor drugs are expanding so rapidly that the number of marketers not offering the products soon could be dwarfed by those competing for market share.
Meeting GLP-1 Users’ Dietary Needs Fills Nutritional Firms' Plate As Major Sales Driver
Brands should “remain flexible and also explore ways to leverage this trend through innovation, consumer education and strategic retailer partnerships,” says Lauren Alexander of market research firm Emerson Group. “This is not a fad,” says Rick Polito of the Nutrition Business Journal.
